PetAction Plus
Commercial- Indications
- Flea and tick control for pets
Company intelligence / Profile preview
Ecto Development Corporation has a 29-year track record of developing, analyzing, and manufacturing animal health products—especially pesticides for flea/tick/ectoparasite control. The company has developed proprietary water-based formulation technology, an enzyme capable of removing permethrin from animal blood, flavoring agents for improved oral medication compliance in dogs, as well as plastic polymer matrix formulations. Its clients include major global pharmaceutical and animal health companies; its products are sold by leading retailers/distributors.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ecto Development.